Phenotype switching in melanoma: implications for progression and therapy

Frontiers in Oncology
Frederic Zhentao LiPetranel T Ferrao

Abstract

Epithelial-mesenchymal transition (EMT) is a key process associated with the progression of epithelial cancers to metastatic disease. In melanoma, a similar process of phenotype switching has been reported and EMT-related genes have been implicated in promotion to a metastatic state. This review examines recent research on the role of signaling pathways and transcription factors regulating EMT-like processes in melanoma and their association with response to therapy in patients, especially response to BRAF inhibition, which is initially effective but limited by development of resistance and subsequent progression. We highlight studies implicating specific roles of various receptor tyrosine kinases (RTKs) in advancing melanoma progression by conferring a proliferative advantage and through promoting invasive phenotypes and metastasis. We also review the current knowledge of the mechanisms underlying resistance to BRAF inhibition and the potential role of melanoma phenotype switching in this process. In particular, we discuss how these important new insights may significantly enhance our ability to predict patterns of melanoma progression during treatment, and may facilitate rational development of combination therapies in the fu...Continue Reading

References

Mar 1, 1994·The Journal of Investigative Dermatology·N J BallJ P Hoeffler
May 12, 2000·Nature Cell Biology·S Fukuhara, J S Gutkind
Apr 20, 2001·The Journal of Biological Chemistry·M A Perez-MorenoA Cano
Aug 30, 2001·Proceedings of the National Academy of Sciences of the United States of America·T BrabletzT Kirchner
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Jul 4, 2002·Cell Biology International·Kwonseop KimElizabeth D Hay
Aug 22, 2002·Nature Reviews. Cancer·Jean Paul Thiery
Dec 1, 2004·Annual Review of Genetics·Eiríkur SteingrímssonNancy A Jenkins
Dec 30, 2004·The Journal of Cell Biology·Amy E LoercherJ William Harbour
Aug 2, 2005·Seminars in Cell & Developmental Biology·Robert A Cornell, Judith S Eisen
Aug 27, 2005·Oncogene·Jiri Zavadil, Erwin P Böttinger
Sep 9, 2005·Frontiers in Bioscience : a Journal and Virtual Library·Lionel Larue, Véronique Delmas
Feb 24, 2006·Nature Reviews. Molecular Cell Biology·Jean Paul Thiery, Jonathan P Sleeman
May 3, 2006·Cancer Research·Michael D OnkenJ William Harbour
Jul 18, 2006·International Journal of Epidemiology·David FisherCatherine Law
Aug 11, 2006·Trends in Molecular Medicine·Carmit LevyDavid E Fisher
Dec 22, 2006·Genes & Development·Suzanne CarreiraColin R Goding
May 18, 2007·Nature Reviews. Cancer·Héctor PeinadoAmparo Cano
Feb 5, 2008·Cancer Research·Keith S HoekReinhard Dummer
Mar 21, 2008·Pigment Cell & Melanoma Research·Dorothy C Bennett
Jun 10, 2008·Developmental Cell·Jing Yang, Robert A Weinberg
Dec 26, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A MicheliUNKNOWN EUROCARE Working Group
Dec 27, 2008·The International Journal of Biochemistry & Cell Biology·Georgia ChalkiadakiGeorge N Tzanakakis
Jan 7, 2009·The Journal of Experimental Medicine·Ramin MassoumiAnja K Bosserhoff
Dec 1, 2009·Cell·Jean Paul ThieryM Angela Nieto
Aug 24, 2010·Pigment Cell & Melanoma Research·Keith S Hoek, Colin R Goding
Sep 8, 2010·The New England Journal of Medicine·Keith T FlahertyPaul B Chapman
Nov 26, 2010·Pigment Cell & Melanoma Research·Petra KoefingerHelmut Schaider
Dec 15, 2010·Nature Reviews. Clinical Oncology·Naoko TakebeS Percy Ivy
May 24, 2011·Pigment Cell & Melanoma Research·Ossia M EichhoffKeith S Hoek

❮ Previous
Next ❯

Citations

Jan 15, 2016·Integrative Biology : Quantitative Biosciences From Nano to Macro·Mousumi MandalJyotirmoy Chatterjee
Mar 30, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Alexander RoeschDirk Schadendorf
Aug 25, 2015·Frontiers in Oncology·Petranel T FerraoErik W Thompson
Jul 19, 2015·Cancer Letters·Mark H ManninoYujiang Fang
Nov 8, 2017·International Journal of Molecular Sciences·Gabriele Romano, Lawrence N Kwong
Sep 6, 2017·Journal of Cell Science·Olivia SusantoRobert H Insall
Sep 6, 2017·Cancer Immunology, Immunotherapy : CII·Sotirios P FortisConstantin N Baxevanis
Mar 27, 2019·Cancers·Iordanka A IvanovaLina Dagnino
Oct 16, 2015·Oncotarget·Luigi StrizziMary J C Hendrix
Mar 23, 2017·Cancer Metastasis Reviews·Mitchell P LevesqueReinhard Dummer
Aug 7, 2019·Scientific Reports·Ádamo Davi Diógenes SienaWilson Araújo Silva
Sep 20, 2019·Journal of Cell Science·Battuya BayarmagnaiBojana Gligorijevic
Nov 11, 2015·The Journal of Biological Chemistry·Natalia RealiniDaniele Piomelli
Jan 8, 2016·Current Opinion in Oncology·Verena PaulitschkeChristoph Höller
Dec 3, 2016·Pigment Cell & Melanoma Research·Nikki R AdlerVictoria J Mar
Mar 27, 2019·Cell Death & Disease·Edward J HartsoughAndrew E Aplin
Aug 30, 2017·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Drenka TrivanovićJuan F Santibanez
Mar 23, 2019·Cell Biology and Toxicology·Jeovanis GilGyörgy Marko-Varga
Oct 10, 2020·Molecular Biology Reports·Marveh RahmatiMohammad Amin Moosavi
Dec 8, 2020·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Charles-Antoine AssenmacherEnrico Radaelli
Aug 15, 2015·Cancer Discovery·Antoni Ribas
May 16, 2019·Cancer Immunology Research·Joseph CursonsMelissa J Davis
Dec 17, 2020·Oncogene·Alexander SwobodaRichard Moriggl

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.